ReP USP - Resultado da busca

Artigo de periodico
Drug nanocrystals in oral absorption: factors that influence pharmacokinetics (2024)
Macedo, Luiza de Oliveira ; Masiero, Jéssica Fagionato ; Bou-Chacra, Nadia Araci
Source: Pharmaceutics. Unidade: FCF
Subjects: FARMACOCINÉTICA, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACEDO, Luiza de Oliveira e MASIERO, Jéssica Fagionato e BOU-CHACRA, Nadia Araci. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics. Pharmaceutics, v. 16, n. 9, p. 1-21 art. 1141, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16091141. Acesso em: 12 nov. 2024.
APA
Macedo, L. de O., Masiero, J. F., & Bou-Chacra, N. A. (2024). Drug nanocrystals in oral absorption: factors that influence pharmacokinetics. Pharmaceutics, 16( 9), 1-21 art. 1141. doi:10.3390/pharmaceutics16091141
NLM
Macedo L de O, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics [Internet]. Pharmaceutics. 2024 ; 16( 9): 1-21 art. 1141.[citado 2024 nov. 12 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16091141
Vancouver
Macedo L de O, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics [Internet]. Pharmaceutics. 2024 ; 16( 9): 1-21 art. 1141.[citado 2024 nov. 12 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16091141
Artigo de periodico
In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors (2024)
Yousef, Malaz ; O’Croinin, Conor; Le, Tyson S; Park, Chulhun ; Zuo, Jieyu; Bou-Chacra, Nadia Araci ; Davies, Neal M ; Löbenberg, Raimar
Source: Pharmaceutics. Unidade: FCF
Subjects: FARMACOCINÉTICA, FARMACODINÂMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 12 nov. 2024.
APA
Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768
NLM
Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 nov. 12 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
Vancouver
Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 nov. 12 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
Artigo de periodico
Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions (2022)
Silva, Daniela Amaral ; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar
Source: Dissolution Technologies. Unidade: FCF
Subjects: TRATO GASTROINTESTINAL, FARMACOCINÉTICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, v. 29, n. 2, p. 62-75, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P62. Acesso em: 12 nov. 2024.
APA
Silva, D. A., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2022). Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, 29( 2), 62-75. doi:10.14227/DT290222P62
NLM
Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 nov. 12 ] Available from: https://doi.org/10.14227/DT290222P62
Vancouver
Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 nov. 12 ] Available from: https://doi.org/10.14227/DT290222P62
Artigo de periodico
Innovative drug delivery systems for leprosy treatment (2022)
Rocha, Nataly Paredes da ; Barbosa, Eduardo José ; Araujo, Gabriel Lima Barros de ; Bou-Chacra, Nadia Araci
Source: Indian Journal of Dermatology. Unidade: FCF
Subjects: HANSENÍASE, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Nataly Paredes da et al. Innovative drug delivery systems for leprosy treatment. Indian Journal of Dermatology, v. 88, n. 3, p. 437-442, 2022Tradução . . Disponível em: https://doi.org/10.25259/ijdvl_1119_20. Acesso em: 12 nov. 2024.
APA
Rocha, N. P. da, Barbosa, E. J., Araujo, G. L. B. de, & Bou-Chacra, N. A. (2022). Innovative drug delivery systems for leprosy treatment. Indian Journal of Dermatology, 88( 3), 437-442. doi:10.25259/ijdvl_1119_20
NLM
Rocha NP da, Barbosa EJ, Araujo GLB de, Bou-Chacra NA. Innovative drug delivery systems for leprosy treatment [Internet]. Indian Journal of Dermatology. 2022 ; 88( 3): 437-442.[citado 2024 nov. 12 ] Available from: https://doi.org/10.25259/ijdvl_1119_20
Vancouver
Rocha NP da, Barbosa EJ, Araujo GLB de, Bou-Chacra NA. Innovative drug delivery systems for leprosy treatment [Internet]. Indian Journal of Dermatology. 2022 ; 88( 3): 437-442.[citado 2024 nov. 12 ] Available from: https://doi.org/10.25259/ijdvl_1119_20
Artigo de periodico
A BCS-based biowaiver approach using biphasic dissolution test (2021)
Silva, Daniela Amaral; Melo, Katherine Jasmine Curo; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar
Source: Dissolution Technology. Unidade: FCF
Subjects: BIOEQUIVALÊNCIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, v. 28, n. 4, p. 40-48, 2021Tradução . . Disponível em: https://doi.org/10.14227/DT280421P40. Acesso em: 12 nov. 2024.
APA
Silva, D. A., Melo, K. J. C., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2021). A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, 28( 4), 40-48. doi:10.14227/DT280421P40
NLM
Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 nov. 12 ] Available from: https://doi.org/10.14227/DT280421P40
Vancouver
Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 nov. 12 ] Available from: https://doi.org/10.14227/DT280421P40
Artigo de periodico
Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics (2021)
Repin, Ilia Alekseevich; Loebenberg, Raimar ; DiBella, John; Conceição, António C. L; Piedade, Manuel E. Minas da ; Ferraz, Humberto Gomes ; Issa, Michele Georges ; Bou-Chacra, Nadia Araci ; Ermida, Catharine Fonseca Martins; Araujo, Gabriel Lima Barros de
Source: AAPS PharmSciTech. Unidade: FCF
Subjects: POLIMORFISMO, FARMACOCINÉTICA, SOLUBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REPIN, Ilia Alekseevich et al. Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics. AAPS PharmSciTech, v. 22, p. 1-11 art. 54, 2021Tradução . . Disponível em: https://doi.org/10.1208/s12249-021-01923-0. Acesso em: 12 nov. 2024.
APA
Repin, I. A., Loebenberg, R., DiBella, J., Conceição, A. C. L., Piedade, M. E. M. da, Ferraz, H. G., et al. (2021). Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics. AAPS PharmSciTech, 22, 1-11 art. 54. doi:10.1208/s12249-021-01923-0
NLM
Repin IA, Loebenberg R, DiBella J, Conceição ACL, Piedade MEM da, Ferraz HG, Issa MG, Bou-Chacra NA, Ermida CFM, Araujo GLB de. Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics [Internet]. AAPS PharmSciTech. 2021 ; 22 1-11 art. 54.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1208/s12249-021-01923-0
Vancouver
Repin IA, Loebenberg R, DiBella J, Conceição ACL, Piedade MEM da, Ferraz HG, Issa MG, Bou-Chacra NA, Ermida CFM, Araujo GLB de. Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics [Internet]. AAPS PharmSciTech. 2021 ; 22 1-11 art. 54.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1208/s12249-021-01923-0
Artigo de periodico
The Significance of disintegration testing in pharmaceutical development (2018)
Silva, Daniela Amaral; Webster, Gregory K; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Source: Dissolution Technologies. Unidade: FCF
Subjects: FARMACOCINÉTICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. The Significance of disintegration testing in pharmaceutical development. Dissolution Technologies, v. 25, n. 3, p. 30-38, 2018Tradução . . Disponível em: https://doi.org/10.14227/DT250318P30. Acesso em: 12 nov. 2024.
APA
Silva, D. A., Webster, G. K., Bou-Chacra, N. A., & Löbenberg, R. (2018). The Significance of disintegration testing in pharmaceutical development. Dissolution Technologies, 25( 3), 30-38. doi:10.14227/DT250318P30
NLM
Silva DA, Webster GK, Bou-Chacra NA, Löbenberg R. The Significance of disintegration testing in pharmaceutical development [Internet]. Dissolution Technologies. 2018 ; 25( 3): 30-38.[citado 2024 nov. 12 ] Available from: https://doi.org/10.14227/DT250318P30
Vancouver
Silva DA, Webster GK, Bou-Chacra NA, Löbenberg R. The Significance of disintegration testing in pharmaceutical development [Internet]. Dissolution Technologies. 2018 ; 25( 3): 30-38.[citado 2024 nov. 12 ] Available from: https://doi.org/10.14227/DT250318P30
Artigo de periodico
Evaluation of the DDSolver software applications (2014)
Zuo, Jieyu; Gao, Yuan; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Source: BioMed Research International. Unidade: FCF
Subjects: SOFTWARES, FARMACOCINÉTICA, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZUO, Jieyu et al. Evaluation of the DDSolver software applications. BioMed Research International, p. 1-9 art. 204925, 2014Tradução . . Disponível em: https://doi.org/10.1155/2014/204925. Acesso em: 12 nov. 2024.
APA
Zuo, J., Gao, Y., Bou-Chacra, N. A., & Löbenberg, R. (2014). Evaluation of the DDSolver software applications. BioMed Research International, 1-9 art. 204925. doi:10.1155/2014/204925
NLM
Zuo J, Gao Y, Bou-Chacra NA, Löbenberg R. Evaluation of the DDSolver software applications [Internet]. BioMed Research International. 2014 ; 1-9 art. 204925.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1155/2014/204925
Vancouver
Zuo J, Gao Y, Bou-Chacra NA, Löbenberg R. Evaluation of the DDSolver software applications [Internet]. BioMed Research International. 2014 ; 1-9 art. 204925.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1155/2014/204925

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Non normalized affiliation